Fertility Tracking Apps Market Size, Share & Industry Analysis, By App Type (Menstrual Cycle & Ovulation Tracking Apps, Conception & Pregnancy Planning Apps, Fertility Treatment Support Apps, Male Fertility Apps, and Others), By Application (Fertility Tracking, Ovulation Monitoring, Menstrual Health Management, Pregnancy Planning, Fertility Treatment Management, Reproductive Health Education, and Others), By Platform (Apple App Store, Google Play Store, and Others), By End User (Individual Users, Hospitals, Fertility Clinics, and Others), and Regional Forecast, 2026-2034

The global fertility tracking apps market size was valued at USD 584.5 million in 2025. The market is projected to grow from USD 670.6 million in 2026 to USD 1,903.7 million by 2034, exhibiting a CAGR of 13.93% during the forecast period.

The global market is anticipated to grow owing to rising awareness regarding reproductive health and increasing adoption of digital tools for menstrual cycle tracking, ovulation monitoring, and pregnancy planning. Fertility app developers are focusing on integrating data analytics, artificial intelligence, symptom tracking, and connected devices to improve fertility predictions and provide personalized health insights. Key companies are also expanding their offerings through partnerships with fertility technology providers and healthcare organizations, supporting greater accessibility to fertility monitoring solutions and overall market growth.

• In July 2025, Clue partnered with Ovum to expand access to affordable fertility tools for consumers across the U.K. The partnership combined Clue's menstrual health tracking platform with Ovum's fertility solutions to support users across their fertility journeys.

Furthermore, major players, such as Flo Health Inc., NaturalCycles Nordic AB, BioWink GmbH, and Xiamen Meet You Co., Ltd., are actively participating in strategic collaborations and acquisitions. These strategies are adopted to expand their offerings, facilitate interchangeability, enhance market access, and strengthen their market presence.

FERTILITY APPS MARKET TRENDS

Increasing Integration of AI-Enabled Fertility Guidance to Enhance Personalized Reproductive Health Management

The increasing integration of AI-enabled fertility guidance is an emerging global market trend. Fertility app developers are incorporating advanced algorithms to analyze menstrual cycle history, ovulation test results, basal body temperature, symptoms, and other user-recorded information to provide more personalized fertility insights. These applications help users to understand their reproductive health information better. Key companies are also introducing conversational AI and adaptive fertility guidance within premium app offerings, aiming to improve user engagement and strengthen the value proposition of subscription-based fertility platforms. The growing focus on personalized and data-driven reproductive health management is therefore expected to accelerate the adoption of AI-enabled capabilities across fertility apps. 

• In October 2025, Premom launched its Fertility AI functionality, including Fertility AI Pro, within its fertility app. The AI-enabled feature analyzes users' recorded information, including menstrual history, LH test results, basal body temperature, symptoms, and other fertility-related data, to provide personalized fertility guidance and explanations.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Rising Adoption of Cycle and Ovulation Tracking Apps to Drive Market Growth

The increasing adoption of cycle and ovulation tracking applications is expected to drive the global fertility tracking apps market growth. Consumers are increasingly using fertility apps to monitor menstrual cycles, identify fertile windows, predict ovulation, and receive personalized insights for conception planning. While basic tracking functions help attract a large user base, premium subscriptions enable app developers to monetize these users by offering advanced cycle analytics, conception guidance, pregnancy tracking, wearable integration, and personalized reproductive health insights. Increasing conversion of free users into paid subscribers therefore generates recurring subscription revenue and encourages companies to expand premium functionalities, supporting overall market growth continuously. 

• In May 2025, Clue announced that it had surpassed 1 million paid subscribers, more than doubling its subscriber base from around 500,000 in May 2024.

MARKET RESTRAINTS

Privacy, Data-security Risks, and Complex Regulatory Compliance to Restrain Market Growth

Growing concerns regarding privacy and data security across countries are expected to restrain the global market growth. These fertility applications collect highly sensitive information, including menstrual cycles, ovulation patterns, pregnancy status, symptoms, sexual activity, and other reproductive health data. Consequently, app developers are required to strengthen consent management, encryption, data minimization, third-party data-sharing controls, deletion mechanisms, and breach-response procedures. The compliance burden becomes more complex for companies operating internationally, as health data receives heightened protection.

• A 2025 study published in the Journal of Medical Internet Research evaluated the privacy practices of four women's health apps, including Clue, Flo, Period Tracker by GP Apps, and Stardust. Further, identifying concerns involving IP-address tracking, third-party involvement in advertising and marketing, and potential misuse of reproductive health data. The researchers concluded that user expectations for data privacy were not being fully met and recommended stronger encryption, anonymization, reduced data collection, and greater transparency regarding third-party sharing.

MARKET OPPORTUNITIES

Expansion of Fertility-treatment and Clinic Workflow Support to Create New Growth Opportunities

The increasing use of fertility apps for fertility-treatment management and clinic workflow support is expected to create significant growth opportunities. Fertility applications are gradually expanding beyond menstrual and ovulation tracking to support patients undergoing IVF, IUI, egg freezing, and other assisted reproductive treatments. These applications can help patients manage medication schedules, appointments, treatment milestones, test results, clinical documents, and personalized treatment timelines in one platform. For fertility clinics, integration of patient-facing applications with clinical workflows can improve communication, reduce repetitive administrative activities, and provide patients with easier access to treatment-related information.

• In December 2025, OTO Coach launched OTO Fertility, a digital health platform patented biometric data and AI-powered insights to predict fertility treatment outcomes. The platform delivers precise data and personalized guidance to support both patients and fertility clinics.

MARKET CHALLENGES

High User Churn and Limited Long-term Engagement to Challenge Revenue Growth

Maintaining consistent and long-term user engagement represents a key challenge for the global market. Repetitive data entry, changing fertility goals, subscription costs, limited perceived value, and declining motivation can cause users to reduce app usage or discontinue tracking over time. For app developers relying on premium subscriptions, weaker engagement can translate into subscription cancellations, lower renewal rates, and higher spending on user reacquisition. Thereby limiting recurring revenue and increases pressure to introduce personalized content and differentiated features continuously.

• For instance, a 2025 study published in the Journal of Pediatric and Adolescent Gynecology evaluated engagement with the T-Dot menstrual-tracking app over six months. Although the application received positive usability ratings, only 64.1% of 156 participants met the study's sustained-engagement criterion, defined as entering data for at least three menstrual periods during the six-month study period. The result fell below the researchers' predefined feasibility target of at least two-thirds of participants demonstrating sustained engagement.

Segmentation Analysis

By App Type

High-frequency Use of Menstrual Cycle & Ovulation Tracking Apps to Support Segment’s Dominance

Based on the app type, the market is categorized into menstrual cycle & ovulation tracking apps, conception & pregnancy planning apps, fertility treatment support apps, male fertility apps, and others.

The menstrual cycle & ovulation tracking apps segment dominated the market in 2025, as menstrual cycle monitoring represents the most common and frequently used functionality across fertility applications. The availability of basic period and ovulation predictions in free versions further lowers the entry barrier and attracts a significantly larger user base. In contrast, advanced predictions and personalized insights encourage users to migrate toward premium subscriptions. Consequently, the combination of broad applicability, frequent engagement, and freemium-to-premium monetization supported the segment's dominant market position.

• In July 2024, Flo Health secured more than USD 200 million in investment from General Atlantic. The company supported nearly 70 million monthly active users and close to 5 million paid subscribers. This large active-user base highlights the strong consumer adoption of period tracking apps and supports the segment's leading contribution to the market.

Male fertility apps are expected to grow at a CAGR of 17.54% over the global fertility tracking apps market forecast period.

To know how our report can help streamline your business, Speak to Analyst

By Application

Growing Reliance on Digital Fertility Tracking for Conception Planning to Drive Segment’s Leadership

Based on application, the market is segmented into fertility tracking, ovulation monitoring, menstrual health management, pregnancy planning, fertility treatment management, reproductive health education, and others.

In 2025, the fertility tracking segment captured the highest share in the market owing to the increasing consumer demand for convenient tools. Fertility tracking provides users with recurring and actionable information generated from menstrual history, ovulation tests, basal body temperature, symptoms, and other fertility indicators. As users increasingly seek personalized information rather than relying only on calendar-based calculations, companies are integrating intelligent algorithms, digital ovulation-test readers, and individualized cycle insights into their applications. This increases the frequency of app usage during the trying-to-conceive journey and strengthens the willingness of consumers to use specialized fertility-tracking functions.

• For instance, in 2026, Premom reported reaching 1.5 million self-reported pregnancies among users of its application and launched PCOS Pro for users with irregular cycles and PCOS management. This development demonstrates the substantial consumer adoption of fertility-tracking tools for understanding ovulation and supporting conception planning.

The others segment is projected to grow at a CAGR of 25.28% during the forecast period.

By Platform

Strong Subscription Monetization on Apple App Store to Support Segment’s Dominance

Based on platform, the market is segmented into Apple App Store, Google Play Store, and others.

The Apple App Store segment dominated the fertility tracking apps market share in 2025 primarily due to the stronger monetization potential of iOS-based subscription applications. Higher conversion of iOS users into paying subscribers therefore allows fertility app developers to generate comparatively greater revenue from the Apple ecosystem even when their applications are available on both major mobile platforms. Also, the established App Store subscription infrastructure and large global iOS user base make the platform commercially attractive for fertility app providers seeking recurring digital revenue.

• For instance, RevenueCat's 2025 State of Subscription Apps study found that the App Store consistently generated stronger subscription monetization than Google Play. Global median day-60 revenue per install stood at approximately USD 0.38 on the App Store compared with USD 0.14 on Google Play. Meanwhile, more than 67% of applications across every analyzed region generated at least 80% of their revenue from iOS users.

The others segment is projected to grow at a CAGR of 18.26% during the forecast period.

By End User

Large Direct-to-consumer User Base Strengthened Dominance of Individual Users

Based on end user, the market is segmented into individual users, hospitals, fertility clinics, and others.

The individual users segment dominated the market in 2025 as fertility applications are primarily designed for end users. These apps are direct-to-consumer digital tools that users can download and operate independently without requiring enrollment with a hospital or fertility clinic. Freemium access, monthly and annual subscriptions, smartphone availability, personalized insights, and the ability to privately manage reproductive health information further encourage direct consumer adoption. Thus, the large population smartphone users of reproductive age and the availability of direct subscription-based access supported the dominance of individual users.

• For instance, in its 2025 year-end update, Natural Cycles stated that its application was being used by millions of users and their partners across more than 50 countries and was available in 15 languages. The company's broad international consumer reach illustrated the scale at which fertility applications are being adopted directly by individuals, supporting the segment's dominant position over hospitals and fertility clinics.

The others segment is projected to grow at a CAGR of 19.75% over the forecast period.

Fertility Tracking Apps Market Regional Outlook

By region, the market is categorized into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America held the dominant share in 2024 at USD 215.5 million and maintained its leading position in 2025 at USD 252.3 million. The region’s market is growing due to strong awareness of reproductive health and widespread adoption of digital health platforms. Increasing use of fertility tracking applications, wearable integration, and clinic-linked digital tools is further supporting market expansion.

U.S. Fertility Tracking Apps Market

Given North America's substantial contribution and the U.S. dominance in the region, the U.S. market is estimated at around USD 229.1 million in 2026, accounting for roughly 38.62% of the global market.

Europe

Europe is projected to grow at 12.60% in the coming years, the second-highest among all regions, and is estimated to reach a valuation of USD 184.1 million by 2026. Market growth in the region is supported by the increasing number of delayed pregnancies witnessed in the region. Thus, these applications support fertility planning, leading to rising adoption of digital reproductive health solutions.

U.K. Fertility Tracking Apps Market

The U.K. market size is estimated at USD 37.5 million in 2026, accounting for roughly 5.59% of the global market.

Germany Fertility Tracking Apps Market

Germany's market value is projected to reach approximately USD 37.8 million by 2026, equivalent to around 5.64% of the global market.

Asia Pacific

Asia Pacific is estimated to reach USD 133.3 million by 2026 and secure the position of the third-largest region in the market. Increasing awareness of infertility and fertility planning is expanding the user base for fertility apps. Countries such as Japan are witnessing declining birth rates. Thereby, these solutions are anticipated to facilitate fertility planning and boost regional growth.

Japan Fertility Tracking Apps Market

The Japanese market size in 2026 is estimated at around USD 22.0 million, accounting for approximately 3.78% of the global market.

China Fertility Tracking Apps Market

China's market is projected to be among the largest worldwide, with 2026 revenues estimated at around USD 41.9 million, accounting for approximately 6.24% of global sales.

India Fertility Tracking Apps Market

The Indian market size in 2026 is estimated at around USD 17.3 million, accounting for roughly 3.22% of global revenue.

Latin America and Middle East & Africa

Latin America is expected to witness significant growth in this market during the forecast period. The market in Latin America is estimated to reach a valuation of USD 38.2 million by 2026. Increasing awareness of menstrual and reproductive health, and growing acceptance of app-based health management are driving adoption in these economies. In the Middle East & Africa region, the GCC market is set to reach USD 12.5 million by 2026.

South Africa Fertility Tracking Apps Market

The South African market size is projected to reach approximately USD 7.1 million by 2026, accounting for roughly 1.06% of global revenue.

COMPETITIVE LANDSCAPE

Key Industry Players

Product Innovation, AI-enabled Fertility Guidance, and Ecosystem Expansion by Key Companies to Intensify Market Competition

The global fertility tracking apps market is moderately fragmented, with key participants including Flo Health Inc., NaturalCycles Nordic AB, BioWink GmbH, and Xiamen Meet You Co., Ltd. These companies are strengthening their market positions through advanced cycle and ovulation prediction, personalized fertility insights, premium subscription models, AI-enabled guidance, wearable integration, and expansion across conception, pregnancy, and broader reproductive-health journeys. Key companies are combining fertility applications with ovulation tests, thermometers, connected devices, and data-driven fertility interpretation, creating a more integrated fertility-monitoring ecosystem.

• In January 2026, Clue partnered with growth investor Verdane through the largest investment in Clue's history to accelerate product innovation, international expansion, healthcare partnerships, clinical research, privacy-first technology, and personalized care. The investment supported deeper feature development and further expansion of its science-based cycle-tracking platform.

Specialized participants are competing through differentiated fertility-monitoring capabilities and targeted consumer experiences. Larger platforms benefit from established brands, extensive user data, subscription monetization, and resources for research and technology development. In contrast, specialized providers compete through focused fertility functionality, connected-device ecosystems, privacy features, differentiated algorithms, and targeted digital communities, resulting in continued product innovation and competitive intensity across the market.

LIST OF KEY FERTILITY TRACKING APPS COMPANIES PROFILED

• Flo Health Inc. (U.K.)
• NaturalCycles Nordic AB (Sweden)
• BioWink GmbH (Germany)
• Xiamen Meet You Co., Ltd. (China)
• Upward Labs Holdings, Inc. (U.S.)
• Simple Design Ltd. (U.K.)
• Ovuline, Inc. (U.S.)
• MAGICFIT LIMITED (Cyprus)
• Easy Healthcare Corporation (U.S.)
• BONGMI LIMITED (China)
• Chengdu Guiyi Technology Co., Ltd. (China)
• Stardust App LLC (U.S.)
• Tamtris Web Services Inc. (Canada)
• GP International LLC (U.S.)
• SimpleInnovation LLC (U.S.)

KEY INDUSTRY DEVELOPMENTS

• August 2026: Natural Cycles partnered with WHOOP to integrate compatible WHOOP wearable devices with its fertility application. The integration enables users to automatically incorporate overnight biomarker information into Natural Cycles for personalized fertility status and reproductive-health insights. This development highlights the increasing focus of fertility app companies on wearable integration to improve convenient and continuous fertility monitoring.
• July 2026: Natural Cycles introduced Custom Trackers, a new functionality that enables users to create personalized tracking categories for symptoms, medications, lifestyle factors, sexual activity, and fertility-treatment information. The functionality can also support users undergoing IVF by allowing them to record injections and treatment-related activities. This development highlights the increasing focus of fertility app companies on personalized tracking capabilities to address diverse reproductive-health and fertility-treatment needs.
• June 2026: Natural Cycles launched NC° Sleep Insights, which combines sleep information from compatible wearable devices with menstrual-cycle and fertility data. The feature provides personalized analysis of sleep patterns according to different cycle phases. This development highlights the increasing focus of fertility app companies on combining reproductive-health data with broader physiological parameters to provide more comprehensive personalized insights.
• May 2026: FutureLife Group partnered with Alife Health to adopt Alife's AI-powered fertility platform across its network of fertility clinics in 16 countries. The platform supports clinical and patient workflows across the IVF journey, including pretreatment planning, embryo assessment, and personalized reporting. This development highlights the increasing focus of fertility technology companies on integrating digital solutions with clinic workflows to improve treatment management and patient engagement.
• May 2026: Alife Health received U.S. FDA clearance for Embryo Predict, its AI-powered software for assisting fertility specialists in embryo assessment during IVF. The platform analyzes embryo images and generates AI-based scores to provide an additional data-driven layer for transfer decisions. This development highlights the increasing focus of fertility technology companies on clinically validated AI solutions to support personalized and data-driven fertility treatment.
• July 2025: Clue introduced Cycle Phase Insights, a personalized feature designed to provide science-based hormonal information across different stages of the menstrual cycle. The feature offers cycle-specific recommendations, community insights, and personalized explanations around hormonal changes, including the ovulation phase. This development highlights the increasing focus of fertility app companies on providing personalized and science-backed cycle intelligence beyond basic period tracking.

REPORT COVERAGE

The global fertility tracking apps market report provides market size estimates and forecasts for all segments covered in the study. The market outlook also evaluates the key drivers, restraints, opportunities, challenges, and emerging trends expected to influence market growth during the forecast period. The report further examines important industry developments, including new feature and product launches, fertility-clinic collaborations, strategic partnerships, investments, and technology advancements. It also presents a comprehensive global market analysis and a detailed competitive landscape covering estimated market shares, product portfolios, business strategies, geographic presence, recent developments, and profiles of key market participants.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation

Research Methodology

1. Bottom-Up Approaches

Approach 1:  Revenues and Market Share of Major Players

• Collection of fertility-app-specific revenue evidence from annual reports, SEC and stock-exchange filings, investor presentations, earnings releases, official company websites, subscription disclosures, and management statements.
• Separation of qualifying fertility-app revenue from fertility hardware, hormone monitors, ovulation test kits, diagnostic consumables, IVF/IUI procedures, teleconsultations, and other non-app businesses.
• Mapping of company portfolios across the key segments.
• Estimation of private-company revenues using paid subscribers, active users, subscription prices, paid downloads, in-app purchases, advertising monetization, and enterprise contracts.
• Adjustment of gross consumer spending for Apple/Google commissions, taxes, refunds, promotional discounts, and payment-processing charges to determine app developer/platform-owner net revenue.
• Calculation of company market shares and estimation of long-tail revenues from smaller and regional fertility-app developers.
• Triangulation of company-level revenues with paid-user, ARPU, platform, regional, and country-level demand indicators.

Approach 2: Paid User, Subscription Conversion and ARPU Analysis

• Estimation of the addressable and active fertility-app user base across individual users, couples, fertility-treatment patients, and other reproductive-health users.
• Classification of registered users, monthly active users, free users, premium subscribers, first-time users, and renewing subscribers by country and application type.
• Assessment of free-to-paid conversion rates, subscription renewal rates, churn, trial conversion, promotional pricing, and annual versus monthly subscription mix.
• Analysis of country-specific subscription prices, premium tiers, in-app purchases, paid features, direct-web subscriptions, and advertising monetization.
• Multiplication of estimated paid subscribers by developer-level net ARPU to derive country-level subscription revenues.
• Addition of attributable paid downloads, in-app purchases, advertising, and other directly monetized fertility-app revenues.
• Validation using disclosed subscriber milestones, app pricing pages, app-store information, company announcements, and digital-platform evidence.

Approach 3:  Fertility App Utilization, Digital Adoption and User-Demand Analysis

• Assessment of the female reproductive-age population and relevant male/couple fertility-user population across countries within the market scope.
• Evaluation of infertility prevalence, people trying to conceive, menstrual and ovulation tracking needs, pregnancy planning, fertility-treatment utilization, and reproductive-health awareness.
• Assessment of smartphone penetration, mobile internet usage, app-store accessibility, digital-health adoption, and willingness to use fertility applications.
• Estimation of fertility-app penetration across fertility tracking, ovulation monitoring, menstrual health management, pregnancy planning, fertility treatment management, and reproductive health education.
• Adjustment for overlapping usage where a consumer may use multiple fertility or menstrual-health applications simultaneously.
• Application of country-specific paid conversion rates and net ARPU to the addressable active-user population.
• Reconciliation of population-derived demand with company revenues, subscriber disclosures, application downloads, and country-level monetization estimates.

2. Top-Down Approaches

Approach 1: Parent-Market, Institutional and Country-Level Demand Analysis

• Establishment of a top-down market ceiling using reproductive-age population, fertility and infertility indicators, smartphone adoption, digital-health penetration, and reproductive-health expenditure from public and institutional sources.
• Application of a fertility-app allocation based on fertility-app usage, paid-subscription penetration, app-store activity, reproductive-health awareness, and digital fertility-care adoption.
• Adjustment of country demand for income levels, purchasing power, smartphone penetration, mobile-payment adoption, fertility-clinic infrastructure, ART utilization, and digital-health maturity.
• Analysis of mature versus emerging markets based on paid-user penetration, ARPU, consumer willingness to pay, regulatory environment, and localized app availability.
• Allocation of regional and country demand across the locked App Type, Application, Platform, and End User segments.
• Comparison with bottom-up revenue estimates, with material differences investigated before final market triangulation.

3. List of Key Sources

• S. Food and Drug Administration (FDA)
• Federal Trade Commission (FTC)
• S. Department of Health & Human Services / Office for Civil Rights
• Centers for Disease Control and Prevention (CDC)
• European Commission
• Medical Device Coordination Group (MDCG)
• Eurostat
• PMDA and Ministry of Health, Labor and Welfare, Japan
• National Medical Products Administration (NMPA)
• CDSCO and Ministry of Electronics & Information Technology, India
• Therapeutic Goods Administration (TGA)
• Office of the Australian Information Commissioner (OAIC)
• World Health Organization (WHO)
• United Nations Population Fund (UNFPA)
• World Bank
• OECD
• National statistical and reproductive-health agencies
• Apple App Store
• Google Play Store
• Company annual reports and financial filings
• Investor presentations and earnings releases
• Company press releases and official websites
• Fertility-clinic, employer, and health-plan partnership disclosures
• Regulatory approvals and Software as a Medical Device databases
• Privacy policies, terms of service, and app update histories

4. Primary Interviews

Supply Side Interviews: 60%

• Key Respondents:
  • Discussions with fertility app developers, women's and reproductive-health technology companies, digital fertility platforms, fertility-treatment support providers, male fertility app developers, and digital-health solution providers.
  • Validation of fertility-app-attributable revenues, subscription pricing, paid subscribers, active users, ARPU, conversion rates, churn, geographic revenue mix, app-store versus direct-web sales, and enterprise contracts.
  • Assessment of competitive positioning, AI and predictive-analytics capabilities, product launches, wearable/device integrations, regulatory strategy, and international expansion.
  • Target respondents include founders, business-development executives, product managers, finance executives, digital-health strategy teams, commercial directors, and regulatory/quality professionals.

Demand Side Interviews: 40%

• Key Respondents:
  • Discussions with fertility clinics, reproductive endocrinologists, gynecologists, hospital digital-health teams, employer fertility-benefit managers, health-plan representatives, and fertility-app users.
  • Validation of fertility-app awareness, adoption, preferred functionality, subscription willingness, renewal behavior, platform preference, fertility-treatment integration, and switching behavior.
  • Assessment of demand for menstrual cycle tracking, ovulation monitoring, conception planning, fertility-treatment support, male fertility solutions, and reproductive-health education.
  • Evaluation of consumer sensitivity to subscription prices, privacy concerns, clinical validation, AI-enabled features, and integration with fertility clinics or wearable devices.
  • Interview findings should be used as validation inputs and should not be treated as standalone market values without confirmation from financial, user, platform, company, or institutional evidence.